Position in PTGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$24,516
+$3,436 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#289
of 341 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $22,018,760 across 201 Biotechnology names. PTGX ranks #40 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VIR |
Vir Biotechnology, Inc.
|
608,234 | $6,197,904 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
341,711 | $2,991,679 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,510 | $2,240,252 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
60,620 | $2,080,478 | |
| 5 | NAUT |
Nautilus Biotechnology, Inc.
|
892,787 | $1,669,511 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
13,058 | $718,190 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,813 | $714,098 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
170,739 | $595,879 |
All Filings in PTGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,516 | 200 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $21,080 | 200 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $19,389 | 222 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $13,286 | 200 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,079 | 110 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,319 | 110 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,246 | 110 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,950 | 110 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,811 | 110 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||